The COVID-19 and Influenza A+B Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A and Influenza B virus antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2/Influenza infection in conjunction with clinical presentation and the results of other laboratory tests.
Fast (15minutes)
Simple Operation (Less Training Required)
Objective (Results Read by Analyzer)
High Accuracy
Product features | Parameters |
Format | Cassette |
Specimen | Nasopharyngeal Swab |
Certificate | CE |
Reading Time | 15 minutes |
Storage Temperature | 2-30°C |
Sensitivity | COVID-19 Test: 97.1%; Influenza A+B Test: Type A(95.0%), Type B: 92.9% |
Specificity | COVID-19 Test: 99.1%; Influenza A+B Test: Type A(99.1%), Type B: 99.1% |
Accuracy | COVID-19 Test: 98.2%; Influenza A+B Test: Type A(98.4%), Type B: 98.1% |
Cat. No. | Product | Specimen | Pack | Cut-off |
ICIC-R525 | COVID-19 and Influenza A+B Antigen Combo Rapid Test | Nasopharyngeal Swab |